Australia orders 84 million doses of COVID-19 vaccine for massive free rollout next year | ABC News
More than 84 million doses of potential coronavirus vaccines will be rolled out to Australians in stages across next year, if "promising" drug trials prove successful. The Federal Government has already announced its intent to purchase a leading international vaccine candidate, from Oxford University and Astrazeneca, for local manufacturing if trials succeed. It has now secured agreement for that vaccine, along with another candidate from the University of Queensland and CSL, also to be produced locally, as part of a $1.7 billion supply and production agreement. Under the deal, early access to the Oxford/AstraZeneca vaccine could see some Australians being vaccinated as soon as January, with 3.8 million doses expected in the first two months of 2021. Australians will only need to take one of the successful vaccine candidates, with an initial dose followed by a booster dose of the same vaccine within weeks. It is likely vulnerable people and front-line health workers will be provided with vaccinations first. In total, the agreements are for 33.8 million doses of an Oxford vaccine and 51 million doses of a UQ vaccine. #CoronavirusVaccine #COVIDVaccineNews Read more here: https://ift.tt/35e4Rqy For more from ABC News, click here: https://ab.co/2kxYCZY You can watch more ABC News content on iview: https://ab.co/2OB7Mk1 Subscribe to us on YouTube: http://ab.co/1svxLVE Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2 You can also like us on Facebook: https://ift.tt/1hqX5dh Or follow us on Instagram: https://ift.tt/1eOTzGY Or even on Twitter: http://twitter.com/abcnews
More than 84 million doses of potential coronavirus vaccines will be rolled out to Australians in stages across next year, if "promising" drug trials prove successful. The Federal Government has already announced its intent to purchase a leading international vaccine candidate, from Oxford University and Astrazeneca, for local manufacturing if trials succeed. It has now secured agreement for that vaccine, along with another candidate from the University of Queensland and CSL, also to be produced locally, as part of a $1.7 billion supply and production agreement. Under the deal, early access to the Oxford/AstraZeneca vaccine could see some Australians being vaccinated as soon as January, with 3.8 million doses expected in the first two months of 2021. Australians will only need to take one of the successful vaccine candidates, with an initial dose followed by a booster dose of the same vaccine within weeks. It is likely vulnerable people and front-line health workers will be provided with vaccinations first. In total, the agreements are for 33.8 million doses of an Oxford vaccine and 51 million doses of a UQ vaccine. #CoronavirusVaccine #COVIDVaccineNews Read more here: https://ift.tt/35e4Rqy For more from ABC News, click here: https://ab.co/2kxYCZY You can watch more ABC News content on iview: https://ab.co/2OB7Mk1 Subscribe to us on YouTube: http://ab.co/1svxLVE Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2 You can also like us on Facebook: https://ift.tt/1hqX5dh Or follow us on Instagram: https://ift.tt/1eOTzGY Or even on Twitter: http://twitter.com/abcnews
Comments
Post a Comment